Clinical Trials in San Diego

Showing 641-660 of 7,028 trials

Intratumoral PH-762 for Cutaneous Carcinoma

NCT06014086

The goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to the drug. Participants will receive four injections of PH-762 at weekly intervals, into a single tumor, followed by surgical removal of the tumor approximately two weeks later.

Squamous Cell Carcinoma of the SkinMalignant Melanoma of SkinMerkel Cell Carcinoma of Skin

Phio Pharmaceuticals Inc.30 participantsStarted Nov 2023

Gilbert, Arizona, United States • San Diego, California, United States • Delray Beach, Florida, United States +2 more locations

RECRUITINGPHASE3< 1 mile

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

NCT06380517

In children 4 to 7 years of age, to determine if treatment with 1 hour per day 6 days per week of watching dichoptic movies/shows wearing the Luminopia headset is non-inferior to treatment with 2 hours of patching per day 7 days per week with respect to change in amblyopic eye distance VA from randomization to 26 weeks.

Amblyopia

Jaeb Center for Health Research238 participantsStarted Jul 2024

Birmingham, Alabama, United States • Glendale, Arizona, United States • Scottsdale, Arizona, United States +70 more locations

Intratumoral PH-762 for Cutaneous Carcinoma

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Find Trials by Condition in San Diego

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

A Study of Barzolvolimab in Patients With Atopic Dermatitis

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Amplatzer Amulet LAAO vs. NOAC

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Galleri® in the Medicare Population.

Study of INCB123667 in Subjects With Advanced Solid Tumors

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Study of ATX-01 in Participants With DM1

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies